DOI: 10.1055/s-00000071

Seminars in Neurology

References

Daniels GH, Vladic A, Brinar V , et al.
Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.

J Clin Endocrinol Metab 2014;
99 (1) 80-89

Download Bibliographical Data

Search in:
Access: